ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins
| | | | | Tissue enriched |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes
| | | | | Tissue enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AGFG2 | ArfGAP with FG repeats 2 | | | | | | Tissue enriched |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Tissue enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AHSP | Alpha hemoglobin stabilizing protein | Plasma proteins
| | | | | Tissue enriched |
AIF1L | Allograft inflammatory factor 1-like | | | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AK5 | Adenylate kinase 5 | Enzymes
| | | | | Tissue enriched |
AK7 | Adenylate kinase 7 | Enzymes
| | | | | Tissue enhanced |
AKAP14 | A kinase (PRKA) anchor protein 14 | | | | | | Group enriched |
AKAP3 | A kinase (PRKA) anchor protein 3 | | | | | | Tissue enriched |
AKAP4 | A kinase (PRKA) anchor protein 4 | Cytoskeleton related proteins
| | | | | Tissue enriched |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
AKR1D1 | Aldo-keto reductase family 1, member D1 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | | | | | | Group enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALLC | Allantoicase | Enzymes
| | | | | Tissue enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
AMBP | Alpha-1-microglobulin/bikunin precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AMER2 | APC membrane recruitment protein 2 | | | | | | Tissue enriched |
AMPD1 | Adenosine monophosphate deaminase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMY2A | Amylase, alpha 2A (pancreatic) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
AMY2B | Amylase, alpha 2B (pancreatic) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANGPTL3 | Angiopoietin-like 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |